Aclarion Inc. (ACONW)
0.03
-0.01 (-16.43%)
At close: Jan 15, 2025, 11:52 AM
undefined% (undefined)
| Bid | 0.02 |
| Market Cap | 1.95M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -6.576 |
| PE Ratio (ttm) | 0 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 0.03 |
| Volume | 25,057 |
| Avg. Volume (20D) | 0 |
| Open | 0.02 |
| Previous Close | 0.04 |
| Day's Range | 0.02 - 0.03 |
| 52-Week Range | 0.02 - 0.03 |
| Beta | undefined |
About ACONW
Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclari...
Sector Healthcare
IPO Date n/a
Employees 4
Stock Exchange NASDAQ
Ticker Symbol ACONW
Website https://www.aclarion.com